- Home
- KRKR vs LGVN Comparison
KRKR vs LGVN Comparison
Compare KRKR & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRKR
- LGVN
- Stock Information
- Founded
- KRKR 2010
- LGVN 2014
- Country
- KRKR China
- LGVN United States
- Employees
- KRKR N/A
- LGVN N/A
- Industry
- KRKR Business Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- KRKR Consumer Discretionary
- LGVN Health Care
- Exchange
- KRKR Nasdaq
- LGVN Nasdaq
- Market Cap
- KRKR 14.5M
- LGVN 16.4M
- IPO Year
- KRKR 2019
- LGVN 2021
- Fundamental
- Price
- KRKR $7.20
- LGVN $0.79
- Analyst Decision
- KRKR
- LGVN Strong Buy
- Analyst Count
- KRKR 0
- LGVN 2
- Target Price
- KRKR N/A
- LGVN $6.50
- AVG Volume (30 Days)
- KRKR 79.8K
- LGVN 330.0K
- Earning Date
- KRKR 09-26-2025
- LGVN 11-11-2025
- Dividend Yield
- KRKR N/A
- LGVN N/A
- EPS Growth
- KRKR N/A
- LGVN N/A
- EPS
- KRKR N/A
- LGVN N/A
- Revenue
- KRKR $30,966,526.00
- LGVN $2,073,000.00
- Revenue This Year
- KRKR $182.55
- LGVN N/A
- Revenue Next Year
- KRKR N/A
- LGVN N/A
- P/E Ratio
- KRKR N/A
- LGVN N/A
- Revenue Growth
- KRKR N/A
- LGVN 68.67
- 52 Week Low
- KRKR $2.76
- LGVN $0.63
- 52 Week High
- KRKR $21.36
- LGVN $2.48
- Technical
- Relative Strength Index (RSI)
- KRKR 51.29
- LGVN 45.59
- Support Level
- KRKR $6.90
- LGVN $0.73
- Resistance Level
- KRKR $7.57
- LGVN $0.82
- Average True Range (ATR)
- KRKR 0.59
- LGVN 0.03
- MACD
- KRKR -0.17
- LGVN 0.01
- Stochastic Oscillator
- KRKR 25.13
- LGVN 66.09
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.